Literature DB >> 20009772

Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.

Ryuichi Suemitsu1, Sadanori Takeo, Hironori Matsuzawa, Masafumi Yamaguchi, Seiya Momosaki, Noriko Uesugi.   

Abstract

OBJECTIVE: A metastatic lymph node commonly becomes enlarge; however, there is limited data available with regard to the direct measurement of lymph nodes and their clinicopathologic characteristics.
METHODS: The size of dissected lymph node was quantified in a total of 848 nodes with metastasis and 10,462 nodes without metastasis from 454 patients with lung cancer who underwent a pulmonary resection with lymph node dissection.
RESULTS: The short axis and the volume of the metastatic lymph nodes were significantly greater than those of the nonmetastatic ones. The smaller the lymph node, the less frequently the lymph nodes were metastatic; however, the ratios of nodes smaller than the fifth largest lymph node with metastasis of adenocarcinoma and squamous cell carcinoma were 21.8 to 26.2%, respectively. When the hilar and mediastinal lymph node stations were examined, 1.14 to 4.00% of the lung cancer patients had lymph node metastasis in small lymph node despite having no metastases in the largest and second largest lymph nodes.
CONCLUSIONS: The small lymph nodes in the hilar or mediastinal stations frequently had metastases of carcinoma even though largest and second largest lymph nodes were negative for metastases, especially in adenocarcinoma cases. Surgical oncologists should, therefore, perform systemic lymph node dissection, and not sampling, during a pulmonary resection of lung cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20009772     DOI: 10.1097/JTO.0b013e3181c6b86b

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  2 in total

1.  Enlarged Mediastinal Lymph Nodes in Computed Tomography are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes.

Authors:  Yuansheng Zheng; Yiwei Huang; Guoshu Bi; Zhencong Chen; Tao Lu; Songtao Xu; Cheng Zhan; Qun Wang
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

2.  Nodal size ranking as a predictor of mediastinal involvement in clinical early-stage non-small cell lung cancer.

Authors:  Cristina Caupena; Roser Costa; Francisco Pérez-Ochoa; Sergi Call; Àngels Jaen; Ramón Rami-Porta; Carme Obiols; Lluis Esteban; Raquel Albero-González; Luis Antonio Luizaga; Mireia Serra; Josep Belda; Xavier Tarroch; José Sanz-Santos
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.